
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
Our resource hub to discover reports, policy papers and other forms of informative content
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
Learn facts and myths about the price of medicines, healthcare cost drivers and the economic contribution of industry.
StatsCan examines the economic footprint made by Canada’s research and development pharmaceutical sector in 2018, including the contributions of Innovative Medicines Canada.
The COVID-19 pandemic has graphically demonstrated the need for a better life sciences environment in Canada. This document outlines the industry’s recommendations for building a thriving sector.
Patented medicines represent 6.6 per cent of healthcare spending in Canada.
Informative content to keep you up to date on the most pressing issues facing our industry.